中文版 | English

在结果中检索

HFCAS OpenIR

浏览/检索结果: 共14条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Drug-resistant HER2-positive breast cancer: Molecular mechanisms and overcoming strategies 期刊论文
FRONTIERS IN PHARMACOLOGY, 2022, 卷号: 13
作者:  Wu, Xiaofan;  Yang, Hongjian;  Yu, Xingfei;  Qin, Jiang-Jiang
收藏  |  浏览/下载：51/0  |  提交时间：2022/12/22
HER2  breast cancer  targeted therapy  drug resistance  overcoming strategies  
Sheep tail fat inhibits the proliferation of non-small-cell lung cancer cells in vitro and in vivo 期刊论文
FRONTIERS IN PHARMACOLOGY, 2022, 卷号: 13
作者:  Xu, Changzhi;  Zhang, Lanlan;  He, Huimin;  Liu, Xiaoyi;  Pei, Xinxin;  Ma, Tengfei;  Ma, Bingbing;  Lin, Wenchu;  Zhang, Buchang
收藏  |  浏览/下载：33/0  |  提交时间：2022/12/23
sheep tail fat  non-small-cell lung cancer  heptadecanoic acid  antiproliferative effect  Akt  S6K signaling pathway  
Inhibition of STAT3 Signaling Pathway by Terphenyllin Suppresses Growth and Metastasis of Gastric Cancer 期刊论文
FRONTIERS IN PHARMACOLOGY, 2022, 卷号: 13
作者:  Yu, Dehua;  Qi, Simin;  Guan, Xiaoqing;  Yu, Wenkai;  Yu, Xuefei;  Cai, Maohua;  Li, Qinglin;  Wang, Weiyi;  Zhang, Weidong;  Qin, Jiang-Jiang
收藏  |  浏览/下载：33/0  |  提交时间：2022/12/23
STAT3  inhibitor  natural product  gastric cancer  terphenyllin  
The Modulation of Chaihu Shugan Formula on Microbiota Composition in the Simulator of the Human Intestinal Microbial Ecosystem Technology Platform and its Influence on Gut Barrier and Intestinal Immunity in Caco-2/THP1-Blue (TM) Cell Co-Culture Model 期刊论文
FRONTIERS IN PHARMACOLOGY, 2022, 卷号: 13
作者:  Liu, Ling;  Lu, Yi;  Xu, Chao;  Chen, Haitao;  Wang, Xuanying;  Wang, Yijie;  Cai, Biyu;  Li, Bing;  Verstrepen, Lynn;  Ghyselinck, Jonas;  Marzorati, Massimo;  Yao, Qinghua
收藏  |  浏览/下载：42/0  |  提交时间：2022/05/16
chaihu shugan formula  gut microbiota  gut barrier  intestinal immunity  SHIMS (R) platform  human  
Editorial: Alcohol Consumption and Liver Diseases: From Pathology to Phytotherapy 期刊论文
FRONTIERS IN PHARMACOLOGY, 2022, 卷号: 13
作者:  Li, Songtao;  Song, Zhenyuan;  Yao, Ping;  Qin, Jiangjiang
收藏  |  浏览/下载：57/0  |  提交时间：2022/05/05
alcoholic liver disease  hepatic steatosis  liver injury  phytochemicals  phytotherapy  
Evaluation of JQ1 Combined With Docetaxel for the Treatment of Prostate Cancer Cells in 2D-and 3D-Culture Systems 期刊论文
FRONTIERS IN PHARMACOLOGY, 2022, 卷号: 13
作者:  Xu, Yipeng;  Pachnikova, Gabriela;  Przybilla, Dorothea;  Schafer, Reinhold;  Cui, Yingying;  Zhou, Dan;  Chen, Zihao;  Zhao, An;  Keilholz, Ulrich
收藏  |  浏览/下载：57/0  |  提交时间：2022/03/28
Prostate Cancer  JQ1  Docetaxel  Combination Treatment  3D Culture Spheroid  
Roles of Major RNA Adenosine Modifications in Head and Neck Squamous Cell Carcinoma 期刊论文
FRONTIERS IN PHARMACOLOGY, 2021, 卷号: 12
作者:  Huo, Xing-xing;  Wang, Shu-jie;  Song, Hang;  Li, Ming-de;  Yu, Hua;  Wang, Meng;  Gong, Hong-xiao;  Qiu, Xiao-ting;  Zhu, Yong-fu;  Zhang, Jian-ye
收藏  |  浏览/下载：54/0  |  提交时间：2022/01/10
RNA modification  N 6-methyladenosine  N 1-methyladenosine  alternative polyadenylation  adenosine-to-inosine editing  head and neck squamous cell carcinoma  immunotherapy  
Cardiotoxicity of Epidermal Growth Factor Receptor 2-Targeted Drugs for Breast Cancer 期刊论文
FRONTIERS IN PHARMACOLOGY, 2021, 卷号: 12
作者:  Yang, ZiYan;  Wang, Wei;  Wang, Xiaojia;  Qin, ZhiQuan
收藏  |  浏览/下载：65/0  |  提交时间：2022/01/10
cardiotoxicity  ErbB2  targeting drugs  breast cancer  therapy  
A Scientometric Visualization Analysis for Natural Products on Cancer Research from 2008 to 2020 期刊论文
FRONTIERS IN PHARMACOLOGY, 2021, 卷号: 12
作者:  Chen, Haitao;  Li, Rongrong;  Zhang, Fan;  Yao, Qinghua;  Guo, Yong
收藏  |  浏览/下载：50/0  |  提交时间：2021/11/01
natural product  cancer  bibliometric  citation analysis  molecular docking  gut microbiota  immune checkpoint  
PROTAC: An Effective Targeted Protein Degradation Strategy for Cancer Therapy 期刊论文
FRONTIERS IN PHARMACOLOGY, 2021, 卷号: 12
作者:  Qi, Si-Min;  Dong, Jinyun;  Xu, Zhi-Yuan;  Cheng, Xiang-Dong;  Zhang, Wei-Dong;  Qin, Jiang-Jiang
收藏  |  浏览/下载：52/0  |  提交时间：2021/06/15
PROTAC  E3 ubiquitin ligase  protein degradation  ubiquitin-proteasome system  cancer therapy